NCT07606066ClinicalTrials.gov
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
En resumen
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient…
Observacional2150 participantes buscados76 centros7 países
Categorías
Registrado en 1 registro
- ClinicalTrials.govNCT07606066Abrir este registro en ClinicalTrials.govSincronizado hace 4 semanas
Un mismo estudio puede estar registrado en varios registros. Lo mostramos una sola vez y enlazamos con todos los registros que tenemos.
La información del ensayo se muestra tal como la publicó el registro, en su idioma original.
¿Le interesa este estudio?
Iniciar sesión o cree una cuenta para registrar su interés y seguir este estudio.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 20 days after the recorded start)First posted 2026-05-26; recorded start 2026-05-06
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 1019 other studies in this databaseCounted from the lead sponsor named in the record (AstraZeneca)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre8/8
Multi-centre: 71 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study, international in scope: 2,150 participants (target), run at 76 sites, across 7 countries.
How this score is built
- Enrolment33/40
2,150 participants (target)
- Site count21/25
71 sites
- Country count12/15
7 countries
- Planned duration5/10
Planned over about 11 months
- Sponsor scale10/10
AstraZeneca has led 991 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Resumen
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
Afecciones
- Type 2 Diabetes
Elegibilidad
| Sexo | Todos |
|---|---|
| Edades | 18 Years – Sin máximo |
| Voluntarios sanos | No |
| Método de muestreo | NON_PROBABILITY_SAMPLE |
Población del estudio
Adults with Type 2 Diabetes
Elegibilidad tal como figura en el registro
Elegibilidad en frases sencillas
Los criterios de este registro aún no se han desglosado en frases separadas. El texto del registro anterior está completo y es la versión autorizada.
Diseño del estudio
| Tipo de estudio | Observacional |
|---|---|
| Fase | No indicado en el registro |
| Asignación | No indicado en el registro |
| Modelo de intervención | No indicado en el registro |
| Propósito principal | No indicado en el registro |
| Enmascaramiento | No indicado en el registro |
| Inscripción | 2150 participantes buscados |
Patrocinador y colaboradores
- AstraZeneca Patrocinador
Grupos e intervenciones
- Participants with Type 2 Diabetes
Participants with Type 2 Diabetes
Intervenciones
- Otro Procedure: assessment
The approximate volume of blood required is 2 mL
Variables de resultado
Variable de resultado principal
Patient demographics
Summary statistics
Plazo Visit 1 (Single day)
Variable de resultado principal
Medical and surgical history
Summary statistics
Plazo Visit 1 (Single day)
Variable de resultado principal
Concomitant medication
Summary statistics
Plazo Visit 1 (Single day)
Variable de resultado principal
HbA1c levels
Summary statistics
Plazo Visit 1 (Single day)
Variable de resultado secundaria
Referral to ongoing or future T2DM study.
Number of participants with high likelihood of meeting eligibility criteria in ongoing or future T2DM studies, for referral to those studies.
Plazo Visit 1 (Single day)
Fechas
| Fecha de inicio | 6 de mayo de 2026 (real) |
|---|---|
| Finalización principal | 31 de marzo de 2027 (estimada) |
| Finalización | 31 de marzo de 2027 (estimada) |
| Primera publicación | 26 de mayo de 2026 (real) |
| Última actualización | 25 de agosto de 2026 |
| Resultados publicados | No indicado en el registro |
| Estado verificado por última vez | marzo de 2026 |
Real significa que el evento ocurrió. Estimada significa que el patrocinador lo prevé. Ambas cosas significan algo distinto.
Ubicaciones
19 centros están en reclutamiento
Brazil
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Research Site | Barretos | Aún no recluta | |
| Research Site | Brasília | Aún no recluta | |
| Research Site | Campinas | São Paulo | Aún no recluta |
| Research Site | Curitiba | Paraná | En reclutamiento |
| Research Site | Fortaleza | Ceará | Aún no recluta |
| Research Site | Natal | Rio Grande do Norte | Aún no recluta |
| Research Site | Porto Alegre | Rio Grande do Sul | Aún no recluta |
| Research Site | Rio de Janeiro | Aún no recluta | |
| Research Site | São José dos Campos | São Paulo | Aún no recluta |
| Research Site | São Paulo | São Paulo | Aún no recluta |
| Research Site | São Paulo | São Paulo | Aún no recluta |
Hungary
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Research Site | Budapest | En reclutamiento | |
| Research Site | Budapest | Aún no recluta | |
| Research Site | Budapest | En reclutamiento | |
| Research Site | Budapest | HU | En reclutamiento |
| Research Site | Budapest | HU | En reclutamiento |
| Research Site | Debrecen | HU | Aún no recluta |
| Research Site | Salgótarján | Aún no recluta | |
| Research Site | Szeged | HU | Aún no recluta |
| Research Site | Szolnok | Aún no recluta | |
| Research Site | Zalaegerszeg | En reclutamiento |
India
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Research Site | Bangalore | Karnataka | Aún no recluta |
| Research Site | Belagavi | Karnataka | Aún no recluta |
| Research Site | Belagavi | Karnataka | Aún no recluta |
| Research Site | Calicut | Kerala | Aún no recluta |
| Research Site | Chennai | Tamil Nadu | Aún no recluta |
| Research Site | Coimbatore | Tamil Nadu | Aún no recluta |
| Research Site | Delhi | New Delhi | Aún no recluta |
| Research Site | Guntur | Andhra Pradesh | Aún no recluta |
| Research Site | Guwahati | Assam | Aún no recluta |
| Research Site | Indore | Madhya Pradesh | Aún no recluta |
| Research Site | Jaipur | Rajasthan | Aún no recluta |
| Research Site | Kochi | Kerala | Aún no recluta |
| Research Site | Kolkata | West Bengal | Aún no recluta |
| Research Site | Lucknow | Uttar Pradesh | Aún no recluta |
| Research Site | Mumbai | Maharashtra | Aún no recluta |
| Research Site | Nagpur | Maharashtra | Aún no recluta |
| Research Site | Pune | Maharashtra | Aún no recluta |
| Research Site | Pune | Maharashtra | Aún no recluta |
| Research Site | Thiruvananthapuram | Kerala | Aún no recluta |
Malaysia
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Research Site | Batu Caves | Selangor | Retirado |
| Research Site | Kuala Lumpur | Wilayah Persekutuan Kuala Lump | Aún no recluta |
| Research Site | Putrajaya | Aún no recluta | |
| Research Site | Seremban | Negeri Sembilan | En reclutamiento |
| Research Site | Seri Manjung | Perak | Aún no recluta |
Poland
| Centro | Ciudad | Estado o región | Estado |
|---|---|---|---|
| Research Site | Bialystok | Podlaskie Voivodeship | En reclutamiento |
| Research Site | Częstochowa | Silesian Voivodeship | Aún no recluta |
| Research Site | Kielce | Świętokrzyskie Voivodeship | Aún no recluta |
| Research Site | Krakow | Malopolska | Aún no recluta |
| Research Site | Lodz | Łódź Voivodeship | En reclutamiento |
En el registro figuran 26 centros más.
Documentos del estudio
No hay documentos enlazados en este registro.
Cambios a lo largo del tiempo
- 25 de agosto de 2026
Centro añadido
5 sites added (76 total)
7176